InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,308.13
(
0.00%
)
US TECH 100
18,156.40
(
-0.22%
)
Dow Jones
39,806.77
(
0.00%
)
Brent Oil
82.59
(
-1.13%
)
Bitcoin
71,174.49
(
-0.38%
)
Post# of 480
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ragraham

Send PM Follow Ignore
Followers 0
Posts 5
Boards Moderated 0
Alias Born 02/06/2012

ragraham

Re: None

Friday, 11/16/2012 1:37:23 PM

Friday, November 16, 2012 1:37:23 PM

Post# of 480
Sangamo BioSciences (SGMO) has several "function cures" of HIV in its clinical trials. SGMO has protected IP in the zinc finger nuclease and TALENs gene-editing platforms. These platforms are "disruptive" in that they represent a way to cure several diseases, rather than treat them. More: http://bit.ly/WayJpR
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SGMO News
More SGMO News
InvestorsHub NewsWire

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!